What is Arcalyst (rilonacept) and what does Kiniksa make?
Arcalyst is a prescription medicine (rilonacept) used to treat certain rare autoinflammatory diseases, most notably cryopyrin-associated periodic syndromes (CAPS) such as familial cold autoinflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS).[1]
Kiniksa is a separate company that develops other immune/inflammatory therapies. If you meant “Arcalyst Kiniksa” as in a company connection (who makes it, who markets it, who is developing alternatives), the key point is that Arcalyst is not a Kiniksa product based on the name match alone. To confirm any specific business tie (co-promotion, acquisition, licensing, or a competitor pipeline overlap), the exact product/company relationship you’re looking for matters.
Is “kiniksa” a different brand name or a misspelling?
“Kiniksa” most commonly refers to Kiniksa Pharmaceuticals, not a brand or formulation of Arcalyst. If you saw “Arcalyst kiniksa” in a document, ad, or patent page, it may be referring to:
- a competitor’s pipeline,
- a company mentioned alongside Arcalyst in a market or patent discussion,
- or a regulatory/patent listing where multiple companies are named.
If you can share where you saw the phrase (for example, a specific website snippet, label, or patent listing), I can map it precisely.
Is Arcalyst still on the market?
Arcalyst is a longstanding therapy used for CAPS. Whether it is currently covered, available in a specific country, or subject to supply limits depends on local regulations and distribution channels.
Patents and exclusivity: who owns what?
If your interest is about patents (for example, whether Kiniksa has any patent claims tied to Arcalyst), a patent tracker like DrugPatentWatch can help identify who is listed as owning key patents and when exclusivity may run out.[2]
Which autoinflammatory conditions does Arcalyst treat?
Arcalyst (rilonacept) is used for CAPS, including FCAS and MWS, which are rare inflammatory syndromes caused by dysregulated inflammation.[1]
---
If you tell me what you mean by “Arcalyst kiniksa” (company relationship, patent question, or condition/indication), I can answer more directly. For example: are you asking whether Kiniksa makes a treatment that competes with Arcalyst, or whether Kiniksa owns any Arcalyst-related patents?
Sources:
[1] https://www.drugs.com/arcalyst.html
[2] https://www.drugpatentwatch.com/